Cardiovascular adverse events in multiple myeloma patients: A comparative study analysis of daratumumab vs. lenalidomide.

Authors: Tejaswi Gadela, Mahati Paravathaneni, Pushan Aggarwal, Eiraj Khan, Arjun Lakshman, Prerna Mewawalla, Santhosh Sadashiv

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e19550

Source: Full article

---

Abstract

e19550